Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 145

    1.

    Optimizing metoclopramide control of cisplatin-induced emesis.

    Meyer BR, Lewin M, Drayer DE, Pasmantier M, Lonski L, Reidenberg MM.

    Ann Intern Med. 1984 Mar;100(3):393-5.PMID: 6538075 [PubMed - indexed for MEDLINE]Related articles

    3.

    Improved control of cisplatin-induced emesis with a combination of high doses of methylprednisolone and metoclopramide: a single-blind randomized trial.

    Bécouarn Y, Nguyen BB, David M, Lakdja F, Brunet R, Chauvergne J.

    Eur J Cancer Clin Oncol. 1986 Dec;22(12):1421-4.PMID: 3595666 [PubMed - indexed for MEDLINE]Related articles

    4.

    High-dose versus low-dose metoclopramide in the prevention of cisplatin-induced emesis. A randomized crossover study in patients with ovarian carcinoma.

    Onsrud M, Moxnes A, Sollien A, Grande T, Solesvik O.

    Cancer. 1988 Jun 15;61(12):2429-32.PMID: 3365665 [PubMed - indexed for MEDLINE]Related articles

    5.

    Clinical pharmacokinetics of high-dose metoclopramide in cancer patients receiving cisplatin therapy.

    McDermed JE, Cohen JL, Joseph C, Strum SB.

    J Clin Oncol. 1985 Oct;3(10):1400-8.PMID: 3900303 [PubMed - indexed for MEDLINE]Related articles

    6.

    Continuous infusion versus intermittent short infusion of metoclopramide for cisplatin-induced acute emesis.

    Saito H, Shimokata K, Yamori S, Kajita M, Niimi T.

    Am J Clin Oncol. 1994 Oct;17(5):422-6.PMID: 8092115 [PubMed - indexed for MEDLINE]Related articles

    7.

    Efficacy & tolerability of ondansetron compared to metoclopramide in dose dependent cisplatin-induced delayed emesis.

    Bhatia A, Tripathi KD, Sharma M.

    Indian J Med Res. 2004 Sep;120(3):183-93.PMID: 15489556 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Optimising antiemesis in cancer chemotherapy: efficacy of continuous versus intermittent infusion of high dose metoclopramide in emesis induced by cisplatin.

    Warrington PS, Allan SG, Cornbleet MA, MacPherson JS, Smyth JF, Leonard RC.

    Br Med J (Clin Res Ed). 1986 Nov 22;293(6558):1334-7. Erratum in: Br Med J (Clin Res Ed) 1986 Dec 13;293(6561):1540. PMID: 3790968 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    A randomized trial of high dose bolus metoclopramide versus low-dose continuous infusion metoclopramide in the prevention of cisplatin-induced emesis.

    Dana BW, McDermott M, Everts E, Abdulhay G.

    Am J Clin Oncol. 1987 Jun;10(3):253-6.PMID: 3296733 [PubMed - indexed for MEDLINE]Related articles

    10.

    Double-blind, multicenter, randomized trial to compare the effect of two doses of adrenocorticotropic hormone versus placebo in controlling delayed emesis after high-dose cisplatin in adult patients with cancer.

    Passalacqua R, Cocconi G, Caminiti C, Silingardi V, Bella MA, Bichisao E, Michiara M, Malavasi V, Donati D, Di Costanzo F, Rocca A, Di Sarra S, Scaglione F, Fraschini F.

    J Clin Oncol. 1997 Jun;15(6):2467-73.PMID: 9196163 [PubMed - indexed for MEDLINE]Related articles

    11.

    Comparison of ondansetron with metoclopramide in prevention of acute emesis associated with low dose & high dose cisplatin chemotherapy.

    Bhatia A, Tripathi KD, Sharma M.

    Indian J Med Res. 2003 Jul;118:33-41.PMID: 14748464 [PubMed - indexed for MEDLINE]Related articles

    12.

    Continuous i.v. infusion versus multiple bolus doses of metoclopramide for prevention of cisplatin-induced emesis.

    Agostinucci WA, Gannon RH, Golub GR, Martin RS, Schauer PK, Dinonno EB.

    Clin Pharm. 1988 Jun;7(6):454-7.PMID: 3402181 [PubMed - indexed for MEDLINE]Related articles

    13.

    The addition of ondansetron to the combination of metoclopramide, dexamethasone, and lorazepam did not improve vomiting prevention in patients receiving high-dose cisplatin.

    Baltzer L, Kris MG, Tyson LB, Rigas JR, Pisters KM.

    Cancer. 1994 Feb 1;73(3):720-3.PMID: 8299095 [PubMed - indexed for MEDLINE]Related articles

    14.

    Ondansetron plus dexamethasone compared to the 'standard' metoclopramide combination.

    Roila F.

    Oncology. 1993 May-Jun;50(3):163-7.PMID: 8459986 [PubMed - indexed for MEDLINE]Related articles

    16.

    Randomized trial comparing two short courses of moderate-dose metoclopramide for moderate-dose cisplatin-induced emesis.

    Pollera CF, Conti EM, De Nigris A, Calabresi F.

    Oncology. 1987;44(2):73-7.PMID: 3554084 [PubMed - indexed for MEDLINE]Related articles

    17.

    Comparison of the efficacy of tropisetron versus a metoclopramide cocktail based on the intensity of cisplatin-induced emesis.

    Chang TC, Hsieh F, Lai CH, Tseng CJ, Cheng HH, Li CL, Michael BJ, Soong YK.

    Cancer Chemother Pharmacol. 1996;37(3):279-85.PMID: 8529290 [PubMed - indexed for MEDLINE]Related articles

    18.

    Examination of the correlation of serum metoclopramide levels with antiemetic efficacy in patients receiving cisplatin.

    Grunberg SM, McDermed JE, Bernstein L, Cohen JL.

    Cancer Chemother Pharmacol. 1987;20(4):332-6.PMID: 3690807 [PubMed - indexed for MEDLINE]Related articles

    19.

    Emesis due to cancer chemotherapy: results of a prospective, randomised, double-blind trial of varying doses of metoclopramide in the management of cis-platinum-induced vomiting.

    Allan SG, Cornbleet MA, Lockhart SP, Warrington PS, Leonard RC, Smyth JF.

    Eur J Cancer Clin Oncol. 1984 Dec;20(12):1481-4.PMID: 6389147 [PubMed - indexed for MEDLINE]Related articles

    20.

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data